Archives

Choose a date range

From To

Choose one or more categories

Categories:



 


Concept Life Sciences launches, acquires three companies in $100M deal

Monday, July 14, 2014 12:42 PM

Concept Life Sciences, a newly formed international scientific laboratory and consultancy business, has made three acquisitions with a combined enterprise value approaching $100 million, following backing from Equistone Partners Europe. Concept Life Sciences acquired Peakdale Molecular, Resource & Environmental Consultants (REC) and Scientific Analysis Laboratories (SAL), which operate a number of sites across the U.K. 

More... »

WIRB Copernicus Group

MGC Diagnostics to acquire Medisoft

Monday, July 14, 2014 12:39 PM

MGC Diagnostics, a global medical technologies company, has acquired Medisoft, a Belgium-based, privately held manufacturer of cardiorespiratory diagnostic products. The company plans to close the transaction Aug. 1. Medisoft has served the cardiorespiratory diagnostics market since 1979 and had 2013 revenues of approximately $6.4 million.

More... »

CRF Health eCOA webinar series

The Pulse on Site Success

Monday, July 14, 2014 07:25 AM

By conservative estimates, the global clinical research industry has experienced an 18% annual growth rate in recent years, spurred by lower labor costs, less competition and larger numbers of treatment-naïve patients in emerging markets.

More... »

Report: Orphan drug approvals up, but high costs pose challenges for patients

Friday, July 11, 2014 02:02 PM

Although the pace of approvals for new orphan drugs—medicines that treat relatively rare conditions—have increased in the U.S. and Europe in recent years, patients are facing growing challenges accessing those drugs, a newly completed study by the Tufts Center for the Study of Drug Development (CSDD) at Tufts University has concluded.

More... »

Analysis finds NHS could experience funding crisis before general election

Friday, July 11, 2014 11:26 AM

According to the Nuffield Trust, the NHS is poorly placed to deal with continuing austerity and could experience a funding crisis before the 2015 General Election. A new panel of 100 health and social care leaders also have raised concerns about the future sustainability of the NHS and social care. The Nuffield Trust’s Health and Social Care Leaders’ panel is a survey of NHS and social care professionals' views on the NHS and the social care system in England, and how it should be developed beyond the 2015 general election.  

More... »

Prostrakan to acquire Archimedes

Friday, July 11, 2014 11:26 AM

ProStrakan Group, a subsidiary of global specialty pharmaceutical company Kyowa Hakko Kirin (KHK), has entered into an agreement with Novo, a private limited liability company fully owned by the Novo Nordisk Foundation, to purchase the entire share capital of Archimedes Pharma for $394 million in cash.

More... »

EMA recommends 39 medicines for marketing authorization in first half of 2014

Friday, July 11, 2014 11:25 AM

Thirty-nine medicines for human use were recommended for marketing authorization by the EMA’s Committee for Medicinal Products for Human Use (CHMP) in the first half of 2014, compared with 44 in first half of 2013 and 33 in first half of 2012.

More... »

Scott Storrer to join Strand Life Sciences as president of North America

Friday, July 11, 2014 10:03 AM

Strand Life Sciences has added Scott Storrer, former president and CEO of Genomind, as Strand Life Sciences president of North America.

More... »

PPD wins awards for multimedia promoting the value of clinical trials

Friday, July 11, 2014 08:58 AM

CRO Pharmaceutical Product Development (PPD) has been recognized with awards for excellence in multimedia and digital communications that demonstrate the importance of clinical research in developing life-changing medical treatments. PPD recently earned four Telly Awards and three Web Health Awards.

More... »

CardioCell begins phase IIa trial using itMSC therapy for chronic heart failure

Thursday, July 10, 2014 02:37 PM

CardioCell, a Stemedica Cell Technologies subsidiary that creates allogeneic stem-cell therapies for cardiovascular indications, has started its phase IIa clinical trial for chronic heart failure (HF) patients with non-ischemic cardiomyopathy.

More... »

CenterWatch Drugs in Clinical Trials
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

July 28

WCG acquires Alliance Biosciences to expand its biosafety oversight capabilities, ensure compliance

Facilitated review meetings for protocol design catching on, decreasing amendments, complexity

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

July

IRB market consolidating rapidly
Private equity driving a new commercial ethical review landscape

Lessons learned from medical device trials
Smaller, faster, more flexible trials hold important insights for pharmaceutical innovation

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

June

CRO market poised for growth and consolidation
Sponsors expanding pipelines, shrinking infrastructure fuel strategic outsourcing

Strategies for success evolving in phase I space
Sites see increasing complexity, more patients, greater focus on efficacy

Already a subscriber?
Log in to your digital subscription.

Purchase the June issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs